Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Price to Book Value : 2.213 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.213 |
| August 27, 2026 | 2.260 |
| August 26, 2026 | 2.300 |
| August 25, 2026 | 2.294 |
| August 24, 2026 | 2.291 |
| August 21, 2026 | 2.233 |
| August 20, 2026 | 2.178 |
| August 19, 2026 | 2.198 |
| August 18, 2026 | 2.087 |
| August 17, 2026 | 1.949 |
| August 14, 2026 | 2.140 |
| August 13, 2026 | 1.945 |
| August 12, 2026 | 1.757 |
| August 11, 2026 | 1.771 |
| August 10, 2026 | 1.737 |
| August 07, 2026 | 1.733 |
| August 06, 2026 | 1.718 |
| August 05, 2026 | 1.723 |
| August 04, 2026 | 1.717 |
| August 03, 2026 | 1.647 |
| July 31, 2026 | 1.631 |
| July 30, 2026 | 1.692 |
| July 29, 2026 | 1.631 |
| July 28, 2026 | 1.661 |
| July 27, 2026 | 1.683 |
| Date | Value |
|---|---|
| July 24, 2026 | 1.659 |
| July 23, 2026 | 1.638 |
| July 22, 2026 | 1.691 |
| July 21, 2026 | 1.719 |
| July 20, 2026 | 1.628 |
| July 17, 2026 | 1.741 |
| July 16, 2026 | 1.678 |
| July 15, 2026 | 1.736 |
| July 14, 2026 | 1.738 |
| July 13, 2026 | 1.751 |
| July 10, 2026 | 1.780 |
| July 09, 2026 | 1.81 |
| July 08, 2026 | 1.866 |
| July 07, 2026 | 1.881 |
| July 06, 2026 | 1.877 |
| July 02, 2026 | 1.802 |
| July 01, 2026 | 1.733 |
| June 30, 2026 | 1.785 |
| June 29, 2026 | 2.157 |
| June 26, 2026 | 2.140 |
| June 25, 2026 | 1.941 |
| June 24, 2026 | 2.050 |
| June 23, 2026 | 2.144 |
| June 22, 2026 | 2.012 |
| June 18, 2026 | 1.956 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.28 |
| BridgeBio Pharma, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
Price to Book Value Related Metrics
| PS Ratio | 7.317 |
| Price | 34.07 |
| Earnings Yield | -0.22% |
| Market Cap | 676.30M |